$TMO

Global DNA microarray market projected to grow from $2.5B in 2025 to $4.7B by 2034 at 7% CAGR, driven by genomic research and personalized medicine demand.

Global targeted DNA-RNA sequencing market to surge from $8.6B in 2025 to $46.9B by 2035, driven by precision medicine adoption and government genomic initiatives.

Plasmid DNA manufacturing market projected to reach $10.8B by 2034 from $2.4B in 2025 on strong gene therapy demand growth.

Pharmaceutical CDMO formulations market projects 10.6% CAGR through 2030, driven by peptide outsourcing and biologic innovations reshaping competitive dynamics.

Billionaire Daniel Loeb's Third Point acquires $TMO stake as company beats Q1 earnings and raises guidance, though stock trades 13.7% below technical averages.

Metagenomics sequencing market projected to grow from $2.5B (2025) to $7.5B (2034) at 13% CAGR, driven by declining sequencing costs and clinical adoption.

Cell culture media bags market projected to reach $2.28B by 2035 from $1.30B in 2025, growing at 5.8% CAGR amid biotech manufacturing expansion.

AAV vector manufacturing market to surge from $874M (2025) to $5.2B (2034) as gene therapy breakthroughs drive demand for specialized production infrastructure.

Medical device CDMO market projected to reach $354B by 2033, expanding at 13.12% CAGR driven by increased outsourcing, connected devices, and home care demand.

Clinical trial data visualization market projected to grow from $0.89B (2025) to $1.82B (2030) at 15.4% CAGR, driven by AI adoption and decentralized trials.

Omics clinical trials market grows 8.8% annually from $31.71B in 2025 to $47.78B by 2030, driven by personalized medicine demand and AI advances.

Global barium carbonate market projected to reach USD 1.33 billion by 2035, growing 6.36% annually from USD 719.64 million in 2025, driven by construction, electronics, and ceramics demand.

Thermo Fisher beats Q1 earnings, raises FY26 guidance on strong bioproduction demand, but warns of modest inflation risks from Middle East tensions.

Global allergy diagnostic market projected to reach $10.77B by 2030 from $6.80B in 2025, driven by technological advances and rising allergies.

Five stocks from software, cybersecurity, healthcare, and telecom sectors maintain strength amid broader selloff, backed by solid earnings growth and operational discipline.

Global NGS market projected to reach $29.5B by 2030 from $14.9B in 2025, with Asia-Pacific experiencing fastest growth driven by precision medicine adoption.

Biopharmaceutical third-party logistics market expected to surge from $140B (2025) to $384B (2032), driven by complex biologics, regulatory demands, and cold-chain technology innovation.

Global DNA read, write, edit market projected to surge from $21.4B in 2024 to $67.7B by 2030, driven by CRISPR advances and genomic diagnostics expansion.

Life sciences validation market projected to grow from $2.7B (2024) to $3.9B (2030) at 6.7% CAGR, driven by regulatory demands and digital transformation.

Global molecular diagnostics market projected to grow from $18.26B in 2025 to $43.50B by 2035, driven by early disease detection demand and advanced technology adoption.